Vimarsana
Biggest News Aggregation in the World

Page 20 - Recent Highlights News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recent Highlights. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recent Highlights Today - Breaking & Trending Today

F-star Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights - Vimarsana News

F-star Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights

Previously announced agreement for F-star Therapeutics to be acquired by invoX Pharma; transaction expected to close in the second half of 2022 License Agreement with Takeda to Develop and... | August 11, 2022

AcelRx Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Vimarsana News

AcelRx Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Advanced Niyad™ supply chain development with a focus on obtaining an Emergency Use Authorization in 2023 $0.6 million net revenue in Q2 2022; fifth...

Ondas Holdings Inc.: Ondas Holdings Reports Second Quarter 2022 Financial and Operational Results - Vimarsana News

Ondas Holdings Inc.: Ondas Holdings Reports Second Quarter 2022 Financial and Operational Results

Secured Initial Volume Order from Siemens Mobility for the Class I Rail 900 MHz NetworkEntered into Definitive Merger Agreement to Acquire Airobotics, a Leading Developer of Autonomous Drone SystemsConference

Eagle Pharmaceuticals Reports Second Quarter 2022 Results - Vimarsana News

Eagle Pharmaceuticals Reports Second Quarter 2022 Results

09.08.2022 - •   Q2 2022 net loss was $(0.74) per basic and diluted share and adjusted non-GAAP net income was $1.58 per basic and $1.56 per diluted share •   Total revenue for Q2 2022 was $74.1 million, compared to $48.1 million in Q2 2021, primarily ...

InspireMD Reports Second Quarter 2022 Financial Results and Provides Business Update - Vimarsana News

InspireMD Reports Second Quarter 2022 Financial Results and Provides Business Update

09.08.2022 - - Generated 47.8% growth in CGuard revenue year-over-year - - Delivered several presentations at LINC 2022 featuring CGuard EPS, including a successful live case transmission - - Announced that endovascular pioneer Dr. Juan Parodi ...